Literature DB >> 24703341

Epidemiology of gout.

Edward Roddy1, Hyon K Choi2.   

Abstract

Gout is the most prevalent inflammatory arthritis in men. The findings of several epidemiologic studies from a diverse range of countries suggest that the prevalence of gout has risen over the past few decades. Although incidence data are scarce, data from the United States suggests that the incidence of gout is also rising. Evidence from prospective epidemiologic studies has confirmed dietary factors (animal purines, alcohol, and fructose), obesity, the metabolic syndrome, hypertension, diuretic use, and chronic kidney disease as clinically relevant risk factors for hyperuricemia and gout. Low-fat dairy products, coffee, and vitamin C seem to have a protective effect.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Etiology; Gout; Hyperuricemia; Incidence; Prevalence

Mesh:

Substances:

Year:  2014        PMID: 24703341      PMCID: PMC4119792          DOI: 10.1016/j.rdc.2014.01.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  80 in total

1.  Milk- and soy-protein ingestion: acute effect on serum uric acid concentration.

Authors:  D R Garrel; M Verdy; C PetitClerc; C Martin; D Brulé; P Hamet
Journal:  Am J Clin Nutr       Date:  1991-03       Impact factor: 7.045

2.  Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.

Authors:  Vidula Bhole; Mary de Vera; M Mushfiqur Rahman; Eswar Krishnan; Hyon Choi
Journal:  Arthritis Rheum       Date:  2010-04

3.  Serum uric acid, serum glucose and diabetes: relationships in a population study.

Authors:  D G Cook; A G Shaper; D S Thelle; T P Whitehead
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

4.  Relationship of metabolic syndrome and obstructive sleep apnea.

Authors:  James M Parish; Terrence Adam; Lynda Facchiano
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

5.  High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors.

Authors:  Ravi Suppiah; Ajith Dissanayake; Nicola Dalbeth
Journal:  N Z Med J       Date:  2008-10-03

6.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

7.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31

9.  Revisiting the pathogenesis of podagra: why does gout target the foot?

Authors:  Edward Roddy
Journal:  J Foot Ankle Res       Date:  2011-05-13       Impact factor: 2.303

10.  Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.

Authors:  Mara A McAdams-DeMarco; Janet W Maynard; Alan N Baer; Josef Coresh
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

View more
  88 in total

1.  Study of epidemiological aspects of hyperuricemia in Poland.

Authors:  Katarzyna Kostka-Jeziorny; Krystyna Widecka; Andrzej Tykarski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

2.  The 3-Year Incidence of Gout in Elderly Patients with CKD.

Authors:  Vivian S Tan; Amit X Garg; Eric McArthur; Ngan N Lam; Manish M Sood; Kyla L Naylor
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

3.  Genetic variations in the CLNK gene and ZNF518B gene are associated with gout in case-control sample sets.

Authors:  Tian-Bo Jin; Yongchao Ren; Xugang Shi; Mutu Jiri; Na He; Tian Feng; Dongya Yuan; Longli Kang
Journal:  Rheumatol Int       Date:  2015-01-17       Impact factor: 2.631

Review 4.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

5.  β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.

Authors:  Emily L Goldberg; Jennifer L Asher; Ryan D Molony; Albert C Shaw; Caroline J Zeiss; Chao Wang; Ludmilla A Morozova-Roche; Raimund I Herzog; Akiko Iwasaki; Vishwa Deep Dixit
Journal:  Cell Rep       Date:  2017-02-28       Impact factor: 9.423

6.  European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2016-05-25       Impact factor: 3.942

7.  Arterial calcification due to CD73 deficiency (ACDC): imaging manifestations of ectopic mineralization.

Authors:  Luis Balmore Gutierrez; Thomas Link; Krishna Chaganti; Daria Motamedi
Journal:  Skeletal Radiol       Date:  2016-08-26       Impact factor: 2.199

8.  Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout.

Authors:  Juan Meng; Yanchun Li; Xiaoxu Yuan; Yuewu Lu
Journal:  Rheumatol Int       Date:  2016-11-23       Impact factor: 2.631

9.  Goals of gout treatment: a patient perspective.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

Review 10.  Gout: optimizing treatment to achieve a disease cure.

Authors:  José Antonio Bernal; Neus Quilis; Mariano Andrés; Francisca Sivera; Eliseo Pascual
Journal:  Ther Adv Chronic Dis       Date:  2016-01-12       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.